Join to View Full Profile
3577 W 13 Mile RdSte 103Royal Oak, MI 48073
Phone+1 248-288-4500
Fax+1 248-288-0450
Dr. Nadeau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1999 - 2002
Case Western Reserve University School of MedicineClass of 1999
Certifications & Licensure
MI State Medical License 2005 - 2027
OH State Medical License 1999 - 2006
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 1 citationsPhase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran
Cancer Chemotherapy and Pharmacology. 2023-09-01 - Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.Mats Någård, Mei-Lin Ah-See, James Strauss, Trisha Wise-Draper, Howard P Safran
Cancer Chemotherapy and Pharmacology. 2023-08-01 - 12 citationsOutcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast IrradiationJ. Ben Wilkinson, Chirag Shah, Mitual Amin, Laura Nadeau, Simona F. Shaitelman
Clinical Breast Cancer. 2017-02-01
Press Mentions
Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
